Stocksigma LogoStocksigma Logo

Zim Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 10,545 (+18.9% YoY | +12.0% QoQ) ■ EBITDA: 543 (-5.7% YoY | +121.5% QoQ) ■ EBITDA Margin (%): 5.1 (-134 bps YoY | +255 bps QoQ) ■ PAT: -205

Zim Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Zim Laboratories Ltd · Outcome · 04 Nov 2026, 8:06 pm

Zim Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 10,545 (+18.9% YoY | +12.0% QoQ) ■ EBITDA: 543 (-5.7% YoY | +121.5% QoQ) ■ EBITDA Margin (%): 5.1 (-134 bps YoY | +255 bps QoQ) ■ PAT: -205 (-382.6% YoY | +49.0% QoQ) ■ EPS (INR): -0.38 (-322.2% YoY | +49.3% QoQ)

Original exchange filing (PDF)

More announcements from Zim Laboratories Ltd

All Zim Laboratories Ltd announcements